Skip to main content
NeuronFeed
Home Investors Saras Capital

Saras Capital

Active VC
Portfolio Active
1
Latest Converge Bio
Deal flow
$25M
1 round
Unicorns
0
≥ $1B valuation
Founded
Latest
Converge Bio

About Saras Capital

Venture capital firm tracking 1 AI investment, with focus on Drug Discovery and US startups. Total tracked deal flow: $25M.

Sector focus

Geographic focus

Portfolio

1

Co-investors

3

Recent rounds

1
Series A $25M Converge Bio